{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:46:29Z","timestamp":1792547189985,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Drug Discovery for Intractable Infectious Diseases Project, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.bbagen.2015.02.012","type":"journal-article","created":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T07:35:41Z","timestamp":1425022541000},"page":"1245-1252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Action mechanism of 6, 6\u2032-dihydroxythiobinupharidine from Nuphar japonicum, which showed anti-MRSA and anti-VRE activities"],"prefix":"10.1016","volume":"1850","author":[{"given":"Shinya","family":"Okamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakano","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomofusa","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2015.02.012_bb0005","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/jcp.14.4.385","article-title":"Methicillin-resistant staphylococci","volume":"14","author":"Barber","year":"1961","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/jac\/42.2.199","article-title":"Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50","volume":"42","author":"Hanaki","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0015","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1086\/527392","article-title":"Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006","volume":"46","author":"Sievert","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jac\/dks354","article-title":"The emerging problem of linezolid-resistant Staphylococcus","volume":"68","author":"Gu","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0025","doi-asserted-by":"crossref","first-page":"310","DOI":"10.7164\/antibiotics.46.310","article-title":"Structures of enzymatically modified products of arbekacin by methicillin-resistant. Staphylococcus aureus","volume":"46","author":"Kondo","year":"1993","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.bbagen.2015.02.012_bb0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1348-0421.2004.tb03489.x","article-title":"Mechanisms of action of corilagin and tellimagrandin I that remarkably potentiate the activity of beta-lactams against methicillin-resistant Staphylococcus aureus","volume":"48","author":"Shiota","year":"2004","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0035","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1348-0421.2005.tb03732.x","article-title":"Remarkable synergies between baicalein and tetracycline, and baicalein and beta-lactams against methicillin-resistant Staphylococcus aureus","volume":"49","author":"Fujita","year":"2005","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0040","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1248\/bpb.31.1794","article-title":"Anti-methicillin resistant Staphylococcus aureus (MRSA) compounds isolated from Laurus nobilis","volume":"31","author":"Otsuka","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0045","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1248\/cpb.37.1735","article-title":"Tannins and related compounds. LXXIX. Isolation and characterization of novel dimeric and trimeric hydrolyzable tannins, nuphrins C, D, E and F from Nuphar japonicum DC.","volume":"37","author":"Ishimatsu","year":"1989","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1248\/cpb.24.2521","article-title":"Constituents of Rhizoma Nupharis. XXVI. Carbon-13 nuclear magnetic resonance spectra of nupharamine, anhydronupharamine, nuphamine, and related compounds","volume":"24","author":"Itatani","year":"1976","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0055","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3987\/COM-97-7878","article-title":"Crude drugs from aquatic plants. VI. On the alkaloid constituents of Chinese Nupharis rhizoma, the dried rhizoma of Nuphar pumilum (TIMM.) DC. (Nymphaceae): structures and rearrangement reaction of thiohemiaminal type nuphar alkaloids","volume":"45","author":"Yoshikawa","year":"1997","journal-title":"Heterocycles"},{"key":"10.1016\/j.bbagen.2015.02.012_bb0060","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1254\/jjp.31.391","article-title":"Actions of desoxynupharidine hydrochloride in the central nervous system of experimental animals (I)","volume":"31","author":"Suzuki","year":"1981","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0065","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/jps.2600620530","article-title":"Isolation and in vitro antifungal activity of 6,6\u2032-dihydroxythiobinupharidine","volume":"62","author":"Cullen","year":"1973","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0070","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1248\/bpb.19.1241","article-title":"Potent immunosuppressive principles, dimeric sesquiterpene thioalkaloids, isolated from nupharis rhizoma, the rhizoma of Nuphar pumilum (nymphaeaceae): structure-requirement of nuphar-alkaloid for immunosuppressive activity","volume":"19","author":"Yamahara","year":"1996","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0075","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1128\/JB.187.7.2426-2438.2005","article-title":"Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain","volume":"187","author":"Gill","year":"2005","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0080","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(00)04403-2","article-title":"Whole genome sequencing of meticillin-resistant Staphylococcus aureus","volume":"357","author":"Kuroda","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2015.02.012_bb0085","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1128\/AAC.39.7.1414","article-title":"Incidence of various gyrA mutants in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolones","volume":"39","author":"Takenouchi","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0090","series-title":"Gram-positive Pathogens","first-page":"381","article-title":"Staphylococcus aureus NCTC8325 genome","author":"Gillaspy","year":"2006"},{"key":"10.1016\/j.bbagen.2015.02.012_bb0095","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1128\/JB.00027-11","article-title":"Whole-genome sequencing of Staphylococcus aureus strain RN4220, a key laboratory strain used in virulence research, identifies mutations that affect not only virulence factors but also the fitness of the strain","volume":"193","author":"Nair","year":"2011","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0100","first-page":"135","article-title":"Restoration of effectiveness of beta-lactams on methicillin-resistant Staphylococcus aureus by tellimagrandin I from rose red","volume":"185","author":"Shiota","year":"2000","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0105","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/BF02029541","article-title":"Structures and allelopathic effects of Nuphar alkaloids: nupharolutine and 6,6\u2032-dihydroxythiobinupharidine","volume":"22","author":"Elakovich","year":"1996","journal-title":"J. Chem. Ecol."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0110","first-page":"4","article-title":"Microbroth dilution methods for determination of minimum inhibitory concentrations","volume":"38","author":"J.S.O. Chemotherapy","year":"1990","journal-title":"Chemotherapy"},{"key":"10.1016\/j.bbagen.2015.02.012_bb0115","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1128\/AAC.00470-11","article-title":"Antistaphylococcal activities of the new fluoroquinolone JNJ-Q2","volume":"55","author":"Morrow","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-59745-246-5_2","article-title":"Methods to assay inhibitors of DNA gyrase and topoisomerase IV activities","volume":"142","author":"Fisher","year":"2008","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0125","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2958.1994.tb00458.x","article-title":"Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones","volume":"13","author":"Ferrero","year":"1994","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0130","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1021\/cb400592n","article-title":"Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions","volume":"8","author":"Aldred","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0135","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nsmb.1892","article-title":"Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance","volume":"17","author":"Wohlkonig","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0140","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.bmcl.2005.12.032","article-title":"Nuphar alkaloids with immediately apoptosis-inducing activity from Nuphar pumilum and their structural requirements for the activity","volume":"16","author":"Matsuda","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/msb4100135","article-title":"Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli","volume":"3","author":"Dwyer","year":"2007","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0150","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2958.1994.tb01026.x","article-title":"The 24kDaN-terminal sub-domain of the DNA gyrase B protein binds coumarin drugs","volume":"12","author":"Gilbert","year":"1994","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0155","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1073\/pnas.75.10.4838","article-title":"Energy coupling in DNA gyrase and the mechanism of action of novobiocin","volume":"75","author":"Sugino","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0160","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1073\/pnas.88.16.7160","article-title":"A constant rate of spontaneous mutation in DNA-based microbes","volume":"88","author":"Drake","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2015.02.012_bb0165","doi-asserted-by":"crossref","first-page":"e60589","DOI":"10.1371\/journal.pone.0060589","article-title":"Microevolutionary events involving narrow host plasmids influences local fixation of vancomycin-resistance in Enterococcus populations","volume":"8","author":"Freitas","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2015.02.012_bb0170","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1021\/ja310778t","article-title":"Synthesis of (\u2013)-neothiobinupharidine","volume":"135","author":"Jansen","year":"2013","journal-title":"J. Am. Chem. Soc."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416515000744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416515000744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T20:26:07Z","timestamp":1537820767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416515000744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0304416515000744"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2015.02.012","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Action mechanism of 6, 6\u2032-dihydroxythiobinupharidine from Nuphar japonicum, which showed anti-MRSA and anti-VRE activities","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2015.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}